Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Brainstorm Cell Therapeutics (BCLI) Return on Capital Employed [ROCE] (2011 - 2022)

Updated

Brainstorm Cell Therapeutics (BCLI) reported Return on Capital Employed [ROCE] of -1209.35% for Q4 2022, down 1113.46 percentage points from -95.89% a year earlier and down 844.54 percentage points from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Return on Capital Employed [ROCE] (2011 - 2022) Analysis & Trends

For FY2022, Brainstorm Cell Therapeutics posted Return on Capital Employed [ROCE] of -246.64%, down 174.36 percentage points from FY2021.

  • Return on Capital Employed [ROCE] has a five-year change of -156.59 percentage points (FY2017 to FY2022).
  • By year, Return on Capital Employed [ROCE] came in at -72.28% in FY2021 (+107.10 pp), -179.38% in FY2020 and -275.02% in FY2018 (-184.97 pp).
  • The Q4 2022 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last four quarters, with an average year-over-year change of -83.21 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2021 (a gain of 578.67 percentage points); the low point was Q4 2022 (a drop of 1113.46 percentage points).
  • Per Business Quant data, the three quarters before Q4 2022 came in at -364.82% (Q3 2022), -169.00% (Q2 2022) and -114.50% (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1,209.35%
Sep 30, 2022 -364.82%
Jun 30, 2022 -169.00%
Mar 31, 2022 -114.50%
Dec 31, 2021 -95.89%
Sep 30, 2021 -91.63%
Jun 30, 2021 -77.73%
Mar 31, 2021 -72.63%
Dec 31, 2020 -103.06%
Sep 30, 2020 -142.66%
Jun 30, 2020 -294.96%
Mar 31, 2020 -651.30%
Mar 31, 2019 -545.32%
Dec 31, 2018 -223.70%
Sep 30, 2018 -61.66%
Jun 30, 2018 -106.77%
Mar 31, 2018 -114.40%
Dec 31, 2017 -85.66%
Sep 30, 2017 -166.87%
Jun 30, 2017 -65.76%
API Access

Brainstorm Cell Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEY